Steroid-sensitive nephrotic syndrome (SSNS) is the most common glomerular disease of childhood, with an incidence of approximately 2 per 100 000 children, although it is up to 6 times more common in children of South Asian ethnic origin.
1 At least 80% of children with SSNS will relapse,
2 and relapses are associated with a risk of significant complications, including sepsis, thrombosis, dyslipidemia, and malnutrition.
3 At least 50% of relapses follow intercurrent infections, most commonly upper respiratory tract infections (URTIs)
4-6; furthermore, in children with relapsing SSNS, half or more URTIs will trigger a relapse.
7